Search
12/09/2024
Structural connectivity modifications following deep brain stimulation of the subcallosal cingulate and nucleus accumbens in severe anorexia nervosa
Abellaneda-Pérez, K, Delgado-Martínez, I, Salgado, P, Ginés, JM, Guardiola, R, Vaqué-Alcázar, L, Roca-Ventura, A, Molist-Puigdomènech, R, Manero, RM, Viles-Garcia, M, Medrano-Martorell, S, Bartrés-Faz, D, Pascual-Leone, A, Pérez-Solà, V, Villalba-Martínez, G. Structural connectivity modifications following deep brain stimulation of the subcallosal cingulate and nucleus accumbens in severe anorexia nervosa. ACTA NEUROCHIRURGICA. 2024; 166(1)DOI:10.1007/s00701-024-06258-w. PMID:39261306. IF:1.900(Q2/4D).
10/09/2024
The SORL1 p.Y1816C variant causes impaired endosomal dimerization and autosomal dominant Alzheimer's disease
Jensen, AMG, Raska, J, Fojtik, P, Monti, G, Lunding, M, Bartova, S, Pospisilova, V, van der Lee, SJ, Van Dongen, J, Bossaerts, L, Van Broeckhoven, C, Dols-Icardo, O, Lléo, A, Bellini, S, Ghidoni, R, Hulsman, M, Petsko, GA, Sleegers, K, Bohaciakova, D, Holstege, H, Andersen, OM. The SORL1 p.Y1816C variant causes impaired endosomal dimerization and autosomal dominant Alzheimer's disease. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2024; 121(37)DOI:10.1073/pnas.2408262121. PMID:39226352. IF:9.100(Q1/2D).
01/09/2024
Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain
Gómez-Zorrilla, S, Becerra-Aparicio, F, Sendra, E, Zamorano, L, Grau, I, Pintado, V, Padilla, B, Benito, N, Boix-Palop, L, Fariñas, MC, Peñaranda, M, Gamallo, MR, Martinez, JA, Morte-Romea, E, Del Pozo, JL, Montesinos, IL, Durán-Jordà, X, Ponz, R, Cotarelo, M, Cantón, R, Oliver, A, Ruiz-Garbajosa, P, Horcajada, JP. Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain. JOURNAL OF HOSPITAL INFECTION. 2024; 151DOI:10.1016/j.jhin.2024.05.020. PMID:38945399. IF:3.100(Q1/3D).
30/08/2024
Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine treatment
Belvís, R, Irimia, P, González, N, García-Ull, J, Pozo-Rosich, P, López-Bravo, A, Morollón, N, Quintas, S, Plana, A, Baz, PG, Tentor, A, Artiles, NG, León, FJ, Martín, MP, Rivera, I, Ramírez, R, Colomina, I, Lainez, JM, Pascual, J. Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine treatment. MEDICINA CLINICA. 2024; 163(4)DOI:10.1016/j.medcli.2024.02.006. PMID:38643025. IF:2.100(Q2/3D).
13/08/2024
Impact of repetitive negative thinking on subjective cognitive decline: insights into cognition and brain structure
Mulet-Pons, L, Solé-Padullés, C, Cabello-Toscano, M, Abellaneda-Pérez, K, Perellón-Alfonso, R, Cattaneo, G, Sánchez, JS, Alviarez-Schulze, V, Bargalló, N, Tormos-Muñoz, JM, Pascual-Leone, A, Bartrés-Faz, D, Vaqué-Alcázar, L. Impact of repetitive negative thinking on subjective cognitive decline: insights into cognition and brain structure. Frontiers in Aging Neuroscience. 2024; 16DOI:10.3389/fnagi.2024.1441359. PMID:39193493. IF:4.500(Q1/2D).
01/08/2024
MADRE MIA: Monoclonal Antibody Duration of REsponse in MIgraine After treatment interruption: A prospective multicentric study on 2164 patients
Iñiguez, AE, Peral, ALG, de Teherán, JD, Lasaosa, SS, Godia, EC, Bujanda, MM, Pérez, NR, Juanes, FV, Soblechero, AS, Díez, FI, Fernández, MTT, Baurier, VO, García-Moncó, JC, Arilla, SA, Sánchez, AJ, Mínguez-Olaondo, A, Nieva, AR, Porta-Etessam, J, Zubizarreta, IK, López-Bravo, A, Villanueva, MH, Gago-Viega, A, Oria, CG, López, AA, Sánchez-Mateos, NM, Castrillo, AS, Treviño, C, Sierra-Mencía, A, García, AR, López, JAM, Pérez, MPN, Zorrilla-Lequerica, PM, Escudero, MDA, Ros, AL, Luque, SG, Alvarez, M, Fabra, NF, Colina, NR, Rodriguez-Vico, JS, Salgado, MR, García, NG, Urabayen, AE, Vendrell, AM, Lázaro, IF, del Rincón, CR, Pérez, RL, Layos-Romero, A, Nieto, RB, Osorio, YG, Guisado-Alonso, D, Durán, AO, López, JT, González-Fernández, L, Fernández-Fernández, S, Rodriguez, HM, García, AG, Díaz, SC, Gutierrez, SQ, Rodriguez, NS, Sánchez, MTS, Galindo, TM, Peña, SF, dela Cadiniere, MDLI, Martínez, AG, Azorín, DG. MADRE MIA: Monoclonal Antibody Duration of REsponse in MIgraine After treatment interruption: A prospective multicentric study on 2164 patients. JOURNAL OF HEADACHE AND PAIN. 2024; 25DOI:. PMID:. IF:7.900(Q1/1D).
01/08/2024
The comparative safety and efficacy of anti-migraine medications and devices in migraine prophylaxis: a network meta-analysis
Nieto, RB, Láinez, MJ, Huth, M, Francis, P, Singh, S, McMaster, A, Hasham, SN, Suthar, B, Srivastava, PK. The comparative safety and efficacy of anti-migraine medications and devices in migraine prophylaxis: a network meta-analysis. JOURNAL OF HEADACHE AND PAIN. 2024; 25DOI:. PMID:. IF:7.900(Q1/1D).
01/08/2024
RE-START STUDY: Multicenter study to assess response after reintroduction of anti-CGRP antibodies in patients with migraine
Martínez, AG, del Rincón, CR, Gutierrez, SQ, Azorín, DG, Lázaro, IF, Peral, ALG, Osorio, YG, Díez, FI, Iñiguez, AE, Luque, SG, Villanueva, MH, Díaz, SC, Vendrell, AM, Juanes, FV, Ros, AL, Soblechero, AS, Sánchez-Mateos, NM, Belvis, R, Zubizarreta, IK, Urabayen, AE, Rodrígue-Vico, JS, Sanchez, AJ, García, AG, Pérez, MPN, Montes, N, Gago-Viega, A. RE-START STUDY: Multicenter study to assess response after reintroduction of anti-CGRP antibodies in patients with migraine. JOURNAL OF HEADACHE AND PAIN. 2024; 25DOI:. PMID:. IF:7.900(Q1/1D).